Cynanoside H

Details

Top
Internal ID c9250013-2f44-4ca4-83b0-81c797ec41c5
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Oligosaccharides
IUPAC Name (4S,5R,7R,8R,13R,16R,19R,22S)-7,22-dihydroxy-8-[(2S,4S,5R,6R)-5-[(2S,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.04,13.05,10.019,22]docosa-1(21),10-dien-14-one
SMILES (Canonical) CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3OC)OC4CC5=CCC6C(C5(CC4O)C)CCC7=COC8(C7(C(CO8)OC6=O)O)C)C)C)OC)O
SMILES (Isomeric) C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3OC)O[C@@H]4CC5=CC[C@@H]6[C@@H]([C@]5(C[C@H]4O)C)CCC7=CO[C@@]8([C@]7([C@@H](CO8)OC6=O)O)C)C)C)OC)O
InChI InChI=1S/C41H62O16/c1-19-35(44)29(47-6)14-34(51-19)56-36-20(2)52-32(13-26(36)42)57-37-21(3)53-33(15-30(37)48-7)54-28-12-22-8-10-24-25(39(22,4)16-27(28)43)11-9-23-17-49-40(5)41(23,46)31(18-50-40)55-38(24)45/h8,17,19-21,24-37,42-44,46H,9-16,18H2,1-7H3/t19-,20+,21+,24+,25-,26-,27+,28+,29-,30-,31+,32-,33-,34-,35-,36+,37+,39-,40-,41-/m0/s1
InChI Key JMLUQNLKDNOKLQ-GXSGDHTCSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C41H62O16
Molecular Weight 810.90 g/mol
Exact Mass 810.40378589 g/mol
Topological Polar Surface Area (TPSA) 200.00 Ų
XlogP 0.70
Atomic LogP (AlogP) 2.12
H-Bond Acceptor 16
H-Bond Donor 4
Rotatable Bonds 8

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Cynanoside H

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9799 97.99%
Caco-2 - 0.8768 87.68%
Blood Brain Barrier - 0.6750 67.50%
Human oral bioavailability - 0.7000 70.00%
Subcellular localzation Mitochondria 0.8379 83.79%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8379 83.79%
OATP1B3 inhibitior + 0.9711 97.11%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.7250 72.50%
BSEP inhibitior + 0.9281 92.81%
P-glycoprotein inhibitior + 0.7501 75.01%
P-glycoprotein substrate + 0.7716 77.16%
CYP3A4 substrate + 0.7458 74.58%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8924 89.24%
CYP3A4 inhibition - 0.8680 86.80%
CYP2C9 inhibition - 0.9144 91.44%
CYP2C19 inhibition - 0.9410 94.10%
CYP2D6 inhibition - 0.9379 93.79%
CYP1A2 inhibition - 0.8486 84.86%
CYP2C8 inhibition + 0.6029 60.29%
CYP inhibitory promiscuity - 0.9355 93.55%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.4327 43.27%
Eye corrosion - 0.9906 99.06%
Eye irritation - 0.9160 91.60%
Skin irritation + 0.5684 56.84%
Skin corrosion - 0.9385 93.85%
Ames mutagenesis - 0.5970 59.70%
Human Ether-a-go-go-Related Gene inhibition + 0.6660 66.60%
Micronuclear - 0.8100 81.00%
Hepatotoxicity + 0.5698 56.98%
skin sensitisation - 0.9054 90.54%
Respiratory toxicity + 0.7778 77.78%
Reproductive toxicity + 0.9778 97.78%
Mitochondrial toxicity + 0.7750 77.50%
Nephrotoxicity + 0.5914 59.14%
Acute Oral Toxicity (c) I 0.5461 54.61%
Estrogen receptor binding + 0.8296 82.96%
Androgen receptor binding + 0.7596 75.96%
Thyroid receptor binding - 0.5157 51.57%
Glucocorticoid receptor binding + 0.7581 75.81%
Aromatase binding + 0.6844 68.44%
PPAR gamma + 0.7815 78.15%
Honey bee toxicity - 0.5966 59.66%
Biodegradation - 0.6750 67.50%
Crustacea aquatic toxicity + 0.6200 62.00%
Fish aquatic toxicity + 0.9511 95.11%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.70% 91.11%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 98.61% 85.14%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 97.12% 96.09%
CHEMBL1914 P06276 Butyrylcholinesterase 96.82% 95.00%
CHEMBL4040 P28482 MAP kinase ERK2 95.00% 83.82%
CHEMBL3137262 O60341 LSD1/CoREST complex 94.38% 97.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 93.93% 100.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 91.25% 89.00%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 89.51% 95.89%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 89.29% 94.00%
CHEMBL5608 Q16288 NT-3 growth factor receptor 89.27% 95.89%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 89.22% 95.56%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 88.13% 99.23%
CHEMBL253 P34972 Cannabinoid CB2 receptor 88.12% 97.25%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 86.89% 96.77%
CHEMBL5255 O00206 Toll-like receptor 4 86.76% 92.50%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 86.68% 97.14%
CHEMBL3713062 P10646 Tissue factor pathway inhibitor 86.51% 97.33%
CHEMBL1293249 Q13887 Kruppel-like factor 5 86.38% 86.33%
CHEMBL1871 P10275 Androgen Receptor 83.40% 96.43%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 83.02% 92.62%
CHEMBL4051 P13569 Cystic fibrosis transmembrane conductance regulator 81.56% 95.71%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 81.55% 94.45%
CHEMBL4793 Q86TI2 Dipeptidyl peptidase IX 81.32% 96.95%
CHEMBL1902 P62942 FK506-binding protein 1A 80.18% 97.05%

Cross-Links

Top
PubChem 11205104
NPASS NPC265844
LOTUS LTS0002224
wikiData Q105131515